William Mack & Associates
EVH icon

William Mack & Associates’s Evolent Health EVH Stock Holding History

William Mack & Associates’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.72K Buy
+2,498
New +$11.1K ﹤0.01% 421

Other funds holding EVH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Rubicon Founders
Rubicon Founders Nashville, Tennessee $147M AUM 17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Rock Point Advisors
Rock Point Advisors Burlington, Vermont $402M AUM 17.12% 1-Year Est. Return

William Mack & Associates's EVH Position: Q3 2026 in Review

William Mack & Associates opened a new position in Evolent Health (EVH) in Q3 2026: 2,498 shares worth $8.72K. The stake represents ﹤0.01% of the portfolio and ranks #421 among its holdings.

129 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • William Mack & Associates held 2,498 shares of Evolent Health worth $8.72K as of Q3 2026.
  • Evolent Health was a new William Mack & Associates position in Q3 2026.
  • Evolent Health made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #421 holding.
  • 129 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.